Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook.

Autor: Raja V; Abbott Products Operations AG, Basel, Switzerland., Aguiar C; Department of Cardiology, Hospital Santa Cruz, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal., Alsayed N; Dar Alsaha Medical Center, Bahrain., Chibber YS; WNS Global Services, Noida, India., ElBadawi H; Internal Medicine Department, Wayne State University, Detroit, MI, USA; Metabolic Unit, My Clinic International, Jeddah, Saudi Arabia., Ezhov M; National Medical Research Center of Cardiology n.a. ac. E.I. Chazov, Moscow, Russia., Hermans MP; Université Catholique de Louvain, Brussels, Belgium., Pandey RC; WNS Global Services, Noida, India., Ray KK; Imperial Centre for Cardiovascular Disease Prevention, Imperial College London, UK., Tokgözoglu L; Hacettepe University, Ankara, Turkey., Zambon A; University of Padua, Padua, Italy., Berrou JP; Abbott Products Operations AG, Basel, Switzerland. Electronic address: jean-pascal.berrou@abbott.com., Farnier M; PEC2, EA 7460, University of Bourgogne, Dijon, France. Electronic address: farnier.michel@orange.fr.

Publikováno v: Atherosclerosis [Atherosclerosis] 2023 Oct; Vol. 383, pp. 117312. Date of Electronic Publication: 2023 Sep 30.